available for iOS, Android & web
January 23, 2013
Johnson & Johnson has posted an 8% increase in sales for the fourth quarter, helping by a strong showing at its pharmaceuticals division
July 18, 2012
Johnson & Johnson has kicked off the US reporting season by posting a 49.3% fall in earnings for the second quarter, hit by charges, and healthy sales of new products, notably the prostate cancer drug Zytiga
February 22, 2012
Johnson & Johnson has picked Alex Gorsky to take over from William Weldon as chief executive at the end of April
Recruitment agencies provide the unique bridge to [more]...
International Clinical Researcher of the Year 2016
Book your tickets today!
PharmaTimes 2015 Copyright | RSS Feed Subscriptions